Abstract
Background: The antiallergic and antiasthmatic drug disodium cromoglycate (DSCG) has also demonstrated an activity against sickle cell disease, but the mechanism of this action still remains unknown. Methods: Na<sup>+</sup> and K<sup>+</sup> fluxes were studied in red cells obtained from 9 patients affected with sickle cell disease in the absence or in the presence of 1 mM of DSCG and deoxygenated under an N<sub>2</sub> flow during up to 24 h. Results: A significant inhibiting effect of DSCG on the intracellular K<sup>+</sup> exit and the Na<sup>+</sup> entry was observed. Conclusion: These results demonstrate that DSCG partially inhibits the abnormal K<sup>+</sup> loss which is implicated in the dehydration of the sickle cell and the stimulation of sickling.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
